CSPC Pharmaceutical Group Limited (CSPCY)

CSPC Pharmaceutical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	6,777	12,015	10,298	9,284	7,296
Short-Term Investments	7,767	2,360	1,750	4,268	2,024	2,019
Trading Asset Securities	1,936	-	-	-	-	-
Cash & Short-Term Investments	9,703	9,137	13,765	14,566	11,307	9,316
Cash Growth	-10.29%	-33.62%	-5.50%	28.82%	21.38%	61.67%
Accounts Receivable	8,852	9,542	9,712	6,736	6,508	4,533
Other Receivables	1,001	79.18	129.65	100.05	39.78	129.68
Receivables	9,853	9,621	9,841	6,836	6,549	4,745
Inventory	3,054	3,130	3,139	2,555	2,480	1,861
Total Current Assets	22,610	21,888	26,745	23,957	20,337	15,921
Property, Plant & Equipment	13,014	12,503	11,643	10,977	9,564	8,934
Long-Term Investments	6,614	6,271	4,596	3,720	3,323	2,710
Goodwill	234.9	234.9	234.9	234.9	149.98	149.98
Other Intangible Assets	2,655	2,518	2,146	1,872	425.87	494.6
Long-Term Deferred Tax Assets	203.3	250.3	186.78	113.03	43	117.47
Long-Term Deferred Charges	-	91.8	52.53	35.81	41.98	14.15
Other Long-Term Assets	670.85	632.23	678.51	859.31	857.51	1,728
Total Assets	46,002	44,389	46,282	41,770	34,742	30,070
Accounts Payable	2,288	2,988	2,889	2,206	1,770	1,359
Accrued Expenses	-	3,821	-	3,922	3,166	2,337
Short-Term Debt	-	364.2	441.27	145.64	-	99
Current Portion of Long-Term Debt	247.46	28	8.95	7.84	-	-
Current Portion of Leases	88.79	58.99	149.63	142.07	38.42	124.84
Current Income Taxes Payable	143.98	137.51	379.45	261.61	260.73	378.84
Current Unearned Revenue	659.76	538.05	494.9	940.5	645.75	745.17
Other Current Liabilities	6,685	1,697	5,820	1,333	1,346	1,258
Total Current Liabilities	10,113	9,634	10,183	8,958	7,226	6,302
Long-Term Debt	-	-	-	28.95	-	-
Long-Term Leases	158.75	56.14	107.06	258.04	55.62	92.88
Long-Term Unearned Revenue	439.68	407.81	340.53	270.92	250.2	253.97
Long-Term Deferred Tax Liabilities	427.55	424.73	574.84	611.99	381.48	320.44
Other Long-Term Liabilities	-	-	59.16	-	-	-
Total Liabilities	11,138	10,523	11,264	10,128	7,913	6,969
Common Stock	11,036	11,033	10,899	10,899	10,899	10,899
Additional Paid-In Capital	-	588.85	390.53	196.57	46.79	46.79
Retained Earnings	-	25,650	26,245	23,192	19,188	15,197
Treasury Stock	-	-612.04	-316.21	-83.71	-85.6	-100.71
Comprehensive Income & Other	22,213	-4,394	-4,015	-4,006	-4,062	-3,710
Total Common Equity	33,250	32,265	33,203	30,198	25,987	22,332
Minority Interest	1,614	1,602	1,815	1,444	841.56	768.79
Shareholders' Equity	34,864	33,866	35,018	31,642	26,828	23,101
Total Liabilities & Equity	46,002	44,389	46,282	41,770	34,742	30,070
Total Debt	495	507.33	706.9	582.54	94.04	316.71
Net Cash (Debt)	9,208	8,630	13,058	13,984	11,213	8,999
Net Cash Growth	-11.70%	-33.91%	-6.62%	24.70%	24.61%	61.43%
Net Cash Per Share	0.80	0.74	1.10	1.17	0.94	0.75
Filing Date Shares Outstanding	11,417	11,538	11,852	11,917	11,918	11,955
Total Common Shares Outstanding	11,417	11,538	11,852	11,917	11,918	11,955
Working Capital	12,498	12,254	16,562	14,999	13,110	9,620
Book Value Per Share	2.91	2.80	2.80	2.53	2.18	1.87
Tangible Book Value	30,359	29,512	30,822	28,090	25,411	21,688
Tangible Book Value Per Share	2.66	2.56	2.60	2.36	2.13	1.81
Buildings	-	5,565	5,389	4,639	4,135	3,569
Machinery	-	9,943	9,194	7,317	6,723	5,961
Construction In Progress	-	2,235	1,246	2,245	1,534	1,483

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.